|
HS Code |
916978 |
| Product Name | DL-Buthionine-[S,R]-Sulfoximine |
| Cas Number | 83730-53-4 |
| Molecular Formula | C8H18N2O2S |
| Molecular Weight | 206.31 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water and DMSO |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Chemical Class | Sulfoximine derivative |
| Synonyms | BSO; S-Butylhomocysteine sulfoximine |
| Iupac Name | (2R/S)-2-Amino-4-(butylsulfonimidoyl)butanoic acid |
| Smiles | CCCCS(=O)(=N)C(CC(=O)O)N |
As an accredited DL-Buthionine-[S,R]-Sulfoximine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for DL-Buthionine-[S,R]-Sulfoximine (1 gram) features a sealed amber glass vial with a clear, printed safety label. |
| Shipping | DL-Buthionine-[S,R]-Sulfoximine is shipped in tightly sealed containers, protected from light and moisture. The product is handled as a non-hazardous substance under standard shipping regulations, but care is taken to prevent contamination or degradation. Temperature conditions are typically ambient unless otherwise specified on the safety data sheet (SDS). |
| Storage | DL-Buthionine-[S,R]-Sulfoximine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Protect from moisture, heat, and direct sunlight. Refrigeration (2–8°C) is recommended for long-term stability. Avoid exposure to incompatible materials, such as oxidizing agents. Store away from food and drink, and label clearly to prevent accidental misuse. |
Applications of DL-Buthionine-[S,R]-Sulfoximine in Industrial ManufacturingDL-Buthionine-[S,R]-Sulfoximine is an established specialty intermediate that supports several focused industrial sectors dependent on regulated chemical process inputs and controlled bioactivity modification. Below, we present verified downstream applications based on real market integration, detailed by sector with compliance, formulation, process, and product guidance for professional B2B users. 1. Research-Grade Reagent Production for Glutathione Depletion StudiesSynthesis divisions serving laboratory supply companies use this compound to manufacture targeted research reagents for glutathione depletion assays in cell biology, toxicology, and oncology research. Its established function as a specific glutathione biosynthesis inhibitor supports controlled study design for academic, pharmaceutical, and contract research requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Active Pharmaceutical Ingredient (API) Intermediate in Investigational Oncology DrugsChemical synthesis teams engaged in early-phase drug development incorporate DL-Buthionine-[S,R]-Sulfoximine as a key intermediate during the manufacture of experimental therapies targeting glutathione pathway modulation. This critical route remains limited to preclinical and clinical trial manufacturing under strict regulatory controls. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Crop Science Research Formulations for Plant Oxidative Stress ModulationAgricultural technology firms and plant physiology research units deploy this compound within experimental agrochemical formulations designed to probe glutathione biosynthesis in vivo in crop plants. Use remains experimental, guided by protocols to investigate resistance pathways against oxidative stress and herbicide response. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. High-Throughput Screening (HTS) Library Synthesis for Drug Discovery PlatformsChemical libraries used by biotechnology firms and pharmaceutical discovery groups may include DL-Buthionine-[S,R]-Sulfoximine as a building block in the custom synthesis of diverse small molecules for HTS programs. Its precise sulfur-containing backbone supports the development of new candidate scaffolds for redox or apoptosis modulation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Diagnostic Assay Development for Glutathione Pathway Biomarker QuantificationIn vitro diagnostics manufacturers use DL-Buthionine-[S,R]-Sulfoximine during the creation of reagent sets and calibration standards for the quantification of glutathione pathway biomarkers in biomedical samples. Its inhibitory specificity allows diagnosis and monitoring applications related to oxidative stress and related pathologies in clinical research settings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive DL-Buthionine-[S,R]-Sulfoximine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Being in the specialty chemical business for decades teaches more than any textbook or sales manual could. In our factory, every batch tells its own story, from raw material delivery to that last round of analytics. DL-Buthionine-[S,R]-Sulfoximine, known to many as BSO, stands out on our line both in complexity and its importance to advanced biochemical research. Few products create the same reaction as BSO when a researcher walks through the plant, eager to discuss performance and purity, since a small difference in the molecule can change whole experiment outcomes.
Our team treats BSO with a level of attention reserved for the building blocks feeding into the next breakthrough in glutathione metabolism studies. Lab hands know one thing: quality always starts with sourcing. We invest time vetting thiol-containing amino acid raw materials, and run checks on everything entering the process. It only takes a tiny contaminant to create noise in a high-precision assay, and researchers working on oxidative stress or cell detoxification pathways need crystal-clear data.
The formula for DL-Buthionine-[S,R]-Sulfoximine captures both stereoisomers. This blend, with the S and R forms mixed, provides that authentic research experience where comparison between isomers isn’t limited by availability or price. Some ask for single-isomer BSO, and while we can separate, the vast majority of academic groups and pharmaceutical labs look for the racemic blend because established literature points to strong experimental utility with this form.
Our standard production offers DL-Buthionine-[S,R]-Sulfoximine as a bright white powder, exceeding 98 percent purity by HPLC. The reason boils down to one frustration we all face—trace impurities wreak havoc on downstream experiments, especially in glutathione synthetase inhibition or when studying the regulation of cellular antioxidants. We don’t resort to shortcuts or margin-squeezing modifications. If batch-to-batch consistency falters, so does trust. Every shift, we assign responsibilities to confirm uniform crystallinity and ensure that particle size fits the typical requirements for solution work or solid formulations.
The purpose behind BSO’s wide usage lies in its role as a selective inhibitor of γ-glutamylcysteine synthetase. Few compounds can selectively deplete glutathione inside mammalian cells and offer insights into cellular defense mechanisms under oxidative pressure. Researchers using our BSO engage fields ranging from cancer therapy testing to toxicology and plant science. Take the cancer research teams: they rely on our material to sensitize cells to treatments, using BSO to disable deep-rooted glutathione-based defenses in resistant tumors.
Working with independent labs and university research groups, we continually get feedback on how material consistency speeds up or slows down discovery. Some synthesize BSO in-house to cut costs but eventually return for the reliability that an industrial plant provides. We use purification steps not feasible on smaller scales, removing residual solvents and side-products until what remains matches the reference spectra published in pharmacology journals.
Our staff works with customers sorting through the practicalities of solubility, handling, and stability. Each bottle of BSO has to resist caking, clumping, or hydration from humid air, which can happen rapidly in warm climates or loosely stored labs. We vacuum-dry every batch, package under nitrogen, and double-seal. That may seem excessive to some, but even one complaint about moisture rendering a bottle unusable reinforces our method.
Sending DL-Buthionine-[S,R]-Sulfoximine beyond our walls introduces another level of responsibility. Word spreads fast about a subpar batch, especially given the price tag and the pivotal role BSO plays as a research reagent. Global shipping adds hurdles—temperature swings, extended customs delays, and everything else that goes hand-in-hand with international logistics.
We’ve built up logistics routines through hard lessons: failures to keep shipments dry can ruin otherwise perfect raw material. Our packaging division swears by foil-lined bags, and puts desiccants in every inner container. During the high-humidity summer, we ship smaller bottle sizes, so unused material doesn’t linger open for long stretches. Each batch gets a unique identifier, tracing back through process records, and internal QA teams run randomly selected bottles months after first production to validate ongoing stability.
Too many researchers learn the hard way that not all BSO on the market matches its label claims. Trader and reseller samples often lack key quality documentation or yield ambiguous results on nuclear magnetic resonance (NMR) and mass spectrometry. Sometimes, materials get cut with thioethers or degraded intermediates to make up volume, undermining both safety and legitimacy. We never mess with dilution or adulteration—each bottle contains what the label says, nothing else.
Factory oversight means more than certificate paperwork. The same chemists and operators overseeing the batch synthesis work on the quality controls. Their pride and headaches ride on the results. Everyone onsite can spot the sharp, sulfurous aroma of BSO through a double mask—one of many sensory checks those who don’t work in production never quite appreciate.
Compared to repackaged goods or “bargain” samples, our material produces predictable results. In long-term glutathione studies, unexpected cellular responses reveal when contaminants sneak in at low levels. UC and GC datasets don’t lie, and patterns repeat across labs and continents. Those who run animal studies, for instance, share that the precise depletion profile in glutathione concentrations only arises with clean, factory-produced material, not with hastily bottled or impure powders.
Looking around the plant during BSO production, there’s a quiet hum of focus interrupted only by the clank of glassware or a supervisor’s call. Details matter. From adjusting reaction temperatures to timing precipitation, our operators trust their experience. Automation helps, but no algorithm replaces a human’s quick reaction to a color shift or unexpected haze during purification.
Training ramps up for each new process tech. They learn the smells, the ways a crystalline cake packs differently after washing, and the exact vibration that signals correct drying. New chemists shadow seniors, memorizing each adjustment, and every batch’s analytics tell the story—where a little more vacuum here or an extra filtration there pays off in purity.
Once, a small technical glitch resulted in traces of parent buthionine carrying through into a fraction of product. Lab teams noticed the irregular melting point during QA, caught before shipment. That batch never left the factory, and protocols improved. The memory sticks: vigilance does more for quality than the finest equipment ever made.
Customers aren’t just buyers. They push us to refine every step, asking tough questions about polymorphs, trace contaminants, and byproduct profiles. One university group shared raw data where a previously uncharacterized impurity skewed enzymatic activity measurements. That led us to overhaul the final chromatography step, extending runtime but eliminating a nagging peak that a skilled scientist would spot instantly.
Some labs request customized handling or micro-purification, and we respond with suggestions based on our own R&D. A Brazilian biotech group needed guarantee of nil pesticide residues, so we introduced source audits and extended our pesticide screening. Feedback cycles improve every time because honest criticism beats polite silence. The best improvements—swapping in acid-washed glass, enhanced vacuum sealing, or solvent-specific analytics—all emerge from days spent working closely with research partners.
Research grows more complex every year. The standards for reporting and reproducibility have tightened—in some fields, journals demand near forensic-level proof of compound purity. We’ve watched colleagues in the industry cut corners to meet demand, but that only builds short-term gain and long-term frustration when poor results discolor an otherwise valid study.
Those who work day-to-day with BSO respect its properties. We’ve learned the quirks of handling sulfoximines—it doesn’t tolerate high humidity or high heat for long periods, and the crystalline nature can turn powdery if dried too aggressively. Storage happens under nitrogen, not just for shelf-life, but to reduce any slow hydrolysis or sulfur loss. Each bottle leaves our warehouse marked with manufacture and recommended retest dates, and our retention samples undergo annual testing for spectral and purity markers.
Spillage, even at small scale, lets off that unmistakable odor—a sign that safety protocols get followed, not ignored. Staff keep personal protective equipment at hand, and spill cleanup follows routines drilled in from first day training. Customers occasionally request custom packaging—smaller vials, vacuum-sealed glass, or moisture-barrier lined drums. We accommodate when possible, but always explain why a factory seal best protects the product until time of use.
Plenty of biochemical tools target glutathione metabolism, but BSO’s specificity gives it a unique edge in research environments. Where many so-called thiol-blockers block a broad suite of cysteine pathways, BSO zeroes in on γ-glutamylcysteine synthetase, offering researchers fine control over cellular antioxidant status without imposing confounding secondary effects. This becomes especially important in cancer biology, where a clear, stepwise inhibition clarifies how redox balance shifts can influence chemotherapeutic response.
Other suppliers market mono-isomeric or crude BSO, but the community documents the racemic blend as the gold standard for comparative studies. Isolated S or R forms play their parts in mechanistic research, and, on rare occasions, we produce these as custom orders—always after lengthy dialogue about real need and cost tradeoffs. For the great majority, the blend offers maximum relevance, lining up experimental results with broad literature benchmarks.
Some may suggest other synthetic inhibitors—bromobimane, diethyl maleate, or buthionine sulfoxamine analogs—as equivalent tools. Our factory’s conversations with academic and medical customers suggest otherwise. Most alternatives display off-target effects, leave lingering toxicity signals, or alter cellular structure enough to muddy interpretation. Years of shared reports, paper preprints, and conference data sheets confirm: correctly manufactured BSO produces clean, interpretable glutathione depletion results in both animal and in vitro models.
Whether a product thrives or falters in the market depends on how well it holds up in real-world studies. With BSO, field stories come back frequently. One high-profile cancer center used our batch for tumor sensitivity profiling and found tight reproducibility across hundreds of assays. A plant biology team studying drought resistance reported that only batches handled from our factory, not third-party repacks, gave clear, concentration-dependent responses in glutathione-modulated signaling pathways.
Stories of trouble-free dissolving and clarity in solution remind us why everyday manufacturing discipline pays off. BSO’s powdered texture flows easily from the bottle, rather than clumping or leaving residue at the bottom of a volumetric flask. Aging samples, if stored improperly, develop a faint yellow tint—a signal that oxidation claims yet another bottle and that moisture control remains the enemy. Open dialogue means we learn almost instantly when any bottle fails to meet these basics, fostering a climate where continuous improvement is more than a slogan.
Supplying DL-Buthionine-[S,R]-Sulfoximine involves more than producing a clean molecule. Each order comes with a real sense of accountability to the people advancing science. Listening closely to researchers, tracking emerging requirements, and tweaking our procedures all keep our plant in line with evolving standards. This feedback loop, built up over years, means the quality of BSO that goes out our doors keeps pace with the demands of both new and deeply established research communities.
Only by working directly with those at the lab bench do we adjust and improve. Research doesn’t benefit from shortcuts. Each freshly milled batch becomes a small but significant piece in the collective effort to unravel the mysteries of oxidative biochemistry, cancer resistance, and environmental plant stress. It’s our privilege to serve that progress, one bottle at a time, with an honest product that reflects the hands and minds behind its creation.